Nuveen Asset Management, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$7,143,495
-37.9%
445,355
-10.2%
0.00%
-25.0%
Q2 2023$11,499,111
+224623.7%
496,079
+125.2%
0.00%
+100.0%
Q1 2023$5,117
+41.4%
220,277
-11.7%
0.00%
+100.0%
Q4 2022$3,619
-99.9%
249,364
-12.9%
0.00%
-50.0%
Q3 2022$5,464,000
+2.9%
286,380
-2.0%
0.00%0.0%
Q2 2022$5,308,000
-51.8%
292,126
-32.8%
0.00%
-50.0%
Q1 2022$11,007,000
-30.4%
434,523
-28.5%
0.00%
-20.0%
Q4 2021$15,824,000
-17.8%
608,022
+6.5%
0.01%
-16.7%
Q3 2021$19,255,000
+7.8%
571,025
-2.3%
0.01%
+20.0%
Q2 2021$17,869,000
-3.6%
584,339
-4.0%
0.01%
-16.7%
Q1 2021$18,542,000
+86.9%
608,924
+21.4%
0.01%
+100.0%
Q4 2020$9,922,000
+129.9%
501,745
+51.6%
0.00%
+50.0%
Q3 2020$4,316,000
+15.7%
330,954
+0.6%
0.00%0.0%
Q2 2020$3,729,000
-12.6%
328,876
+10.3%
0.00%0.0%
Q1 2020$4,266,000
-46.3%
298,199
+2.3%
0.00%
-33.3%
Q4 2019$7,941,000
-10.0%
291,634
-5.4%
0.00%
-25.0%
Q3 2019$8,828,000
-52.8%
308,323
-54.3%
0.00%
-42.9%
Q2 2019$18,722,000
+3816.7%
673,941
+4582.1%
0.01%
+133.3%
Q1 2019$478,000
+14.4%
14,3940.0%0.00%0.0%
Q4 2018$418,000
-36.9%
14,3940.0%0.00%
-25.0%
Q3 2018$662,000
+37.3%
14,394
+11.5%
0.00%
+33.3%
Q2 2018$482,000
+26.5%
12,9040.0%0.00%
+50.0%
Q1 2018$381,000
-14.0%
12,9040.0%0.00%
-33.3%
Q4 2017$443,000
-5.1%
12,9040.0%0.00%0.0%
Q3 2017$467,000
+40.2%
12,9040.0%0.00%
+50.0%
Q2 2017$333,000
+6.7%
12,904
-20.6%
0.00%0.0%
Q1 2017$312,000
+9.1%
16,252
-5.1%
0.00%
+100.0%
Q4 2016$286,000
-20.1%
17,130
-1.5%
0.00%
-50.0%
Q3 2016$358,000
-32.7%
17,3950.0%0.00%
-33.3%
Q2 2016$532,000
-19.3%
17,395
-1.2%
0.00%0.0%
Q1 2016$659,000
-14.4%
17,608
-1.3%
0.00%
-25.0%
Q4 2015$770,000
+13.9%
17,841
-1.1%
0.00%0.0%
Q3 2015$676,000
+10.3%
18,0400.0%0.00%
+33.3%
Q2 2015$613,000
+32.7%
18,040
+38.2%
0.00%0.0%
Q1 2015$462,000
-31.7%
13,054
-34.3%
0.00%
-25.0%
Q4 2014$676,000
-60.3%
19,854
-55.0%
0.00%
-60.0%
Q3 2014$1,703,000
-0.9%
44,1540.0%0.01%0.0%
Q2 2014$1,718,000
+13.8%
44,1540.0%0.01%
+11.1%
Q1 2014$1,510,000
+39.9%
44,154
-14.1%
0.01%
+28.6%
Q4 2013$1,079,000
-58.1%
51,424
-53.1%
0.01%
-58.8%
Q3 2013$2,577,000
-17.1%
109,657
-5.3%
0.02%
-19.0%
Q2 2013$3,110,000115,7500.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders